• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过时-温转变理解无定形固体分散体中的成核作用。

Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time-Temperature Transformation.

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-177 WDH, 308 Harvard Street S.E., Minneapolis, Minnesota 55455, United States.

出版信息

Mol Pharm. 2023 Aug 7;20(8):4196-4209. doi: 10.1021/acs.molpharmaceut.3c00313. Epub 2023 Jun 26.

DOI:10.1021/acs.molpharmaceut.3c00313
PMID:37358932
Abstract

In an earlier investigation, the critical cooling rate to prevent drug crystallization (CR) during the preparation of nifedipine (NIF) amorphous solid dispersions (ASDs) was determined through a time-temperature transformation (TTT) diagram (Lalge et al. Mol. Pharmaceutics 2023, 20 (3), 1806-1817). The current study aims to use the TTT diagram to determine the critical cooling rate to prevent drug nucleation (CR) during the preparation of ASDs. ASDs were prepared with each polyvinylpyrrolidone (PVP) and hydroxypropyl methylcellulose acetate succinate (HPMCAS). The dispersions were first stored under conditions promoting nucleation and then heated to the temperature that favors crystallization. The crystallization onset time () was determined by differential scanning calorimetry and synchrotron X-ray diffractometry. TTT diagrams for nucleation were generated, which provided the critical nucleation temperature (50 °C) and the critical cooling rate to avoid nucleation (CR). The strength of the drug-polymer interactions as well as the polymer concentration affected the CR, with PVP having a stronger interaction than HPMCAS. The CR of amorphous NIF was ∼17.5 °C/min. The addition of a 20% w/w polymer resulted in CR of ∼0.05 and 0.2 °C/min and CR of ∼4.1 and 8.1 °C/min for the dispersions prepared with PVP and HPMCAS, respectively.

摘要

在之前的一项研究中,通过时间-温度转变 (TTT) 图确定了硝苯地平 (NIF) 无定形固体分散体 (ASD) 制备过程中防止药物结晶 (CR) 的临界冷却速率( Lalge 等人,《分子药剂学》,2023 年,20 (3),1806-1817)。本研究旨在使用 TTT 图确定制备 ASD 时防止药物成核 (CR) 的临界冷却速率。使用聚乙烯吡咯烷酮 (PVP) 和醋酸羟丙甲纤维素琥珀酸酯 (HPMCAS) 制备 ASD。首先将分散体在促进成核的条件下储存,然后加热至有利于结晶的温度。通过差示扫描量热法和同步加速器 X 射线衍射法确定结晶起始时间 (t0)。生成了成核 TTT 图,提供了临界成核温度 (50°C) 和避免成核的临界冷却速率 (CR)。药物-聚合物相互作用的强度以及聚合物浓度影响 CR,PVP 的相互作用比 HPMCAS 更强。无定形 NIF 的 CR 约为 17.5°C/min。添加 20% w/w 聚合物会导致 PVP 和 HPMCAS 制备的分散体的 CR 分别约为 0.05 和 0.2°C/min 和 CR 分别约为 4.1 和 8.1°C/min。

相似文献

1
Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time-Temperature Transformation.通过时-温转变理解无定形固体分散体中的成核作用。
Mol Pharm. 2023 Aug 7;20(8):4196-4209. doi: 10.1021/acs.molpharmaceut.3c00313. Epub 2023 Jun 26.
2
Implications of Drug-Polymer Interactions on Time-Temperature-Transformation: A Tool to Assess the Crystallization Propensity in Amorphous Solid Dispersions.药物-聚合物相互作用对时间-温度转变的影响:一种评估无定形固体分散体结晶倾向的工具。
Mol Pharm. 2023 Mar 6;20(3):1806-1817. doi: 10.1021/acs.molpharmaceut.2c01004. Epub 2023 Feb 6.
3
Time and Temperature Dependence of Drug Crystallization─The Role of Molecular Mobility.时间和温度对药物结晶的影响——分子迁移率的作用。
Mol Pharm. 2024 Nov 4;21(11):5880-5891. doi: 10.1021/acs.molpharmaceut.4c00935. Epub 2024 Oct 3.
4
A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.喷雾干燥法和热熔挤出法对含非洛地平无定形固体分散体性质影响的比较研究。
J Pharm Pharmacol. 2014 Feb;66(2):275-84. doi: 10.1111/jphp.12099. Epub 2013 Jul 10.
5
Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.聚(2-羟乙基甲基丙烯酸酯)水凝胶中吲哚美辛无定形固体分散体的增强动力学溶解度谱。
Eur J Pharm Biopharm. 2012 May;81(1):149-58. doi: 10.1016/j.ejpb.2011.12.016. Epub 2012 Jan 2.
6
Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.利托那韦无定形固体分散体在水合和溶解过程中的相行为。
Pharm Res. 2017 Dec;34(12):2842-2861. doi: 10.1007/s11095-017-2265-5. Epub 2017 Sep 27.
7
Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.在制备和储存过程中白藜芦醇无定形固体分散体的结晶-不同聚合物的影响。
J Pharm Sci. 2013 Jan;102(1):171-84. doi: 10.1002/jps.23358. Epub 2012 Nov 6.
8
Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.基于醋酸琥珀酸羟丙甲纤维素的无定形固体分散体的热熔挤出:药物物理化学性质的影响。
Carbohydr Polym. 2020 Apr 1;233:115828. doi: 10.1016/j.carbpol.2020.115828. Epub 2020 Jan 10.
9
Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.药物-聚合物混溶性对厄贝沙坦无定形固体分散体焓弛豫的影响。
Pharm Res. 2018 Jan 9;35(2):29. doi: 10.1007/s11095-017-2296-y.
10
Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.聚合物类型和储存相对湿度对非晶态固体分散体中菲洛地平结晶动力学的影响。
Pharm Res. 2009 Dec;26(12):2599-606. doi: 10.1007/s11095-009-9974-3. Epub 2009 Oct 6.

引用本文的文献

1
Monitoring of Isothermal Crystallization and Time-Temperature Transformation of Amorphous Felodipine: The Time-Domain Nuclear Magnetic Resonance Method.无定形非洛地平的等温结晶和时-温转变的监测:时域核磁共振法。
AAPS PharmSciTech. 2024 Sep 19;25(7):219. doi: 10.1208/s12249-024-02919-2.
2
HPMCAS-Based Amorphous Solid Dispersions in Clinic: A Review on Manufacturing Techniques (Hot Melt Extrusion and Spray Drying), Marketed Products and Patents.基于羟丙基甲基纤维素醋酸琥珀酸酯的无定形固体分散体在临床中的应用:关于制造技术(热熔挤出和喷雾干燥)、上市产品及专利的综述
Materials (Basel). 2023 Oct 10;16(20):6616. doi: 10.3390/ma16206616.